CONNECTIVITY
INJECTION
ORAL
RESPIRATORY
COVID-19 NEWS
MORE
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
Subscribe
CONNECTIVITY
INJECTION
ORAL
RESPIRATORY
COVID-19 NEWS
MORE
THE MAGAZINE
EVENTS
EXPERT VIEWS
INTERVIEWS
COMPANIES
OUR AUTHORS
ED CALENDAR
CONTRIBUTE
MEDIA PACK
ABOUT
SEARCH
SEARCH
advanced search
COVID-19 NEWS
COVID-19 NEWS
3P Innovation
CALL FOR HELP IN THE FIGHT AGAINST COVID-19! BUSINESSES UNITE TO SUPPLY 15,000 FACE VISORS A DAY TO NHS
A growing group of businesses is urgently calling for more companies to join its initiative to put in place an end-to-end supply chain for desperately needed protective face visors for NHS and other workers in the fight against COVID-19. The group aims to achieve volumes of approx. 15,000 units/day.
COVID-19 NEWS
DEVICE DESIGN CONSULTANCIES JOIN FORCES, STEP-UP TO THE COVID-19 VENTILATOR CHALLENGE
Leading device design consultancies Cambridge Consultants, PA Consulting, Sagentia, Team Consulting and TTP , with industrial assistance from MetLase, have joined forces to answer the UK government's call for the rapid development and manufacture of vital ventilators for patients suffering with severe symptoms of COVID-19.
COVID-19 NEWS
Development of IMV’s DPX-COVID-19 Vaccine Progresses Apace
Canadian biotech company IMV has made impressively rapid, solid progress on the development of a vaccine candidate against the novel coronavirus, using its lipid-based vaccine delivery platform, DPX. New developments in just two weeks include, include: initiation of peptide candidate manufacturing, cGMP scale-up plans, preclinical models/assays; and Phase I clinical trial design completed, with discussions with Health Canada already underway also.
COVID-19 NEWS
Aquavit Developing Microchannel Drug Delivery Device / Novel Compositions for Vaccine Against COVID-19
Aquavit Pharmaceuticals is applying its AQUAGOLD® microchannel drug delivery device in the development of a self-administered dermal vaccine against COVID-19 caused by the SARS-CoV-2 coronavirus.
COVID-19 NEWS
How the current pandemic will shape healthcare innovation for the next decade
In its COVID-19 announcement, Ximedica has confirmed that its manufacturing facility remains open under the “essential service” classification and that is focusing on US national efforts to help address the challenges surrounding ventilator and PPE supplies. It also highlighted its core strength in engineering, with more than 200 engineers who have established several highly effective means of remote collaboration.
COVID-19 NEWS
Oramed Pharmaceuticals Highlights Potential Suitability of its Platform Technology for COVID-19 Vaccine
In a letter to shareholders issued as an update relating to COVID-19, Oramed Pharmaceuticals has highlighted the suitability of its platform technology for protein-based vaccines, including potentially a vaccine against COVID-19, and the potential for partnerships for such a project.
COVID-19 NEWS
EUROFINS CDMO Launches “Direct To Patient” Service for Continuity of Treatment for Customers’ Clinical Trial Patients
CDMO Eurofins has launched a Direct to Patient service to assure the continued supply of treatments to its customers' clinical trial patients.
COVID-19 NEWS
Stabilitech
Stabilitech to have oral coronavirus vaccine ready for preclinical evaluation in 3 months
UK biopharma company Stabilitech is developing OraPro-COVID-19, applying its OraPro technology with the aim of developing a viral vector with six weeks, and having a capsule ready for animal testing within 12 weeks.
COVID-19 NEWS
Vero Biotech gets okay for expanded access to its Genosyl DS iNO system to treat COVID-19 patients
The US FDA has granted “Expanded Access Emergency Use” to Vero Biotech immediately to use its proprietary inhaled nitric oxide (iNO) delivery system, GENOSYL DS, in the treatment of cardiopulmonary symptoms associated with COVID-19. The agency recently approved GENOSYL (NO) gas, for inhalation for the treatment of persistent pulmonary hypertension of the newborn.
COVID-19 NEWS
N4 Pharma
N4 demonstrating utility of Nuvec
®
vaccine delivery system in COVID-19 vaccines using COVID-19 DNA plasmid
N4 Pharma has initiated a proof of concept project using a Covid-19 DNA plasmid to demonstrate the utility of its Nuvec® silica nanoparticle vaccine delivery system for potential collaboration partners developing Covid-19 DNA or RNA vaccines.
COVID-19 NEWS
Tom Oakley
Springboard
Springboard offers medical device expertise to tackle COVID-19
Springboard is now offering: design reviews / risk assessments of COVID-19 related medical devices at no charge; answering ad hoc requests for advice on devices relevant to COVID-19 at no charge; device development expertise, including a willingness to tackle short term projects on a not-for profit basis; submission of services to the UK Gov call for businesses to help make NHS ventilators.
COVID-19 NEWS
Guy Furness
UPDATE AND NEWS FROM ONDRUGDELIVERY’S PUBLISHER IN RESPONSE TO COVID-19
The world, and our industry with it, has entered an unfamiliar and difficult period. I would like to take this opportunity to update you on how ONdrugDelivery can and will continue to provide its services uninterrupted, and tell you about some specific initiatives we're launching to help our readers, authors and clients across the global industry.
COVID-19 NEWS
Pion
Pion Offers Its Analytical Services Pro Bono if used in the fight against COVID-19
Pion has offered its analytical services
pro bono
to assist in the development of vaccines and therapeutics for use in the fight against COVID-19. Its Scissor SubCutaneous Injection Site Simulator assays "simulate the stress conditions and environmental transitions of a biopharmaceutical drug when injected SC".
COVID-19 NEWS
COVID-19, what’s left to be said and done?…well, everything!
John Cahill, Director, Senior Consultant, Quality & Compliance, PharmaLex Ireland, provides an update on the status of several COVID-19 vaccine and therapeutic development programmes, emphasising the considerable efforts being made by industry, regulatory agencies and others, to accelerate development in what is normally, due to the need for stringent regulation, a notoriously slow-moving sector.
COVID-19 NEWS
Ampio to Study Nebulised Ampion Anti-Inflammatory Biologic in COVID-19 Patients
Ampio Pharmaceuticals is preparing an expanded access US FDA protocol to study potential benefit of nebulised treatment with Ampion in COVID-19-induced acute respiratory distress syndrome (ARDS), an immediately life-threatening condition.
COVID-19 NEWS
Windtree Therapeutics to study its KL4 surfactant for COVID-19 pulmonary effects
Windtree Therapeutics plans a pilot study to assess its KL4 surfactant's ability to impact key respiratory parameters in ventilated COVID-19 patients. The COVID-19 virus infects the specific cells that make pulmonary surfactant and is believed to result in inadequate levels of functional surfactant.
COVID-19 NEWS
eTheRNA launches international consortium, starts development of cross-strain protective CoV-2 mRNA vaccine
An international consortium is pooling resources to develop a nasally delivered, cross-strain protective CoV-2 mRNA vaccine. Clinical testing is scheduled for early 2021. Organisations involves include eTheRNA, EpiVax, REPROCELL, Nexelis, and CEV
COVID-19 NEWS
Gerresheimer
Gerresheimer part of critical infrastructure, products include vital drug delivery devices
In its COVID-19 announcement, Gerresheimer has stated that it is part of the critical infrastructure of the countries in which it operates, producing vital packaging for medicines, drug delivery devices and packaging for food, beverages and hygiene and personal care products.
COVID-19 NEWS
Catalent
Catalent Responds to the Global Outbreak of COVID-19
Catalent has noted that many governments of the countries where it operates have recognised its work as essential meaning all Catalent operating facilities remain open. The company also said it was working with several customers on COVID-related antivirals, vaccines, and treatments for symptoms and effects of the disease.
COVID-19 NEWS
Advanex
With precision metal components being used in inhalers & similar devices, Advanex acknowledges critical role in supply chain
Advanex acknowledges critical role in supply chains with precision metal components being used in inhalers & similar devices, and commits to maintaining supply during turbulent period.
COVID-19 NEWS
E3D – Elcam Drug Delivery Devices
Elcam Medical facilities Recognised by local authorities as essential, enabling continuation of production
All Elcam facilities have been recognised by the local authorities as an essential facility to enable the continuity of production. (See statement by the Israeli Ministry of Economy and Industry). Currently the company does not foresee any disruption to our operation.
COVID-19 NEWS
RDD
Digital RDD 2020 starts April 26, replaces cancelled RDD California
For 2020, RDD is going digital. The organisers, focused on quality, have committed to providing delegates a digital conference venue open 24/7 with the following features: Digital Auditorium; Digital Platinum Sponsor Sessions; Digital Scientific Poster Session; Posters on the Digital Podium; Digital Exhibition; Digital Networking; Digital Library; Digital Personal Proceedings.
COVID-19 NEWS
Lexaria Bioscience
Lexaria Bioscience Expands Pharma Division for development of Lipophilic Antivirals against COVID-19
Lexaria is to investigate how its patented DehydraTECH drug delivery technology could enhance delivery and effectiveness of certain antiviral drugs in the fight against coronavirus disease COVID-19. Lexaria intends to expand collaboration with leading laboratories as soon as possible.
COVID-19 NEWS
ACG
ACG releases letter to customers in response to COVID-19
ACG has released a letter to its customers in response to the COVID-19 outbreak, and reaffirmed its commitment to providing uninterrupted supply of its products and services, and factories in all locations around the world are working at full capacity. ACG has also ensured the supply of its own raw materials for many months.
COVID-19 NEWS
Pfizer
PFIZER OUTLINES FIVE-POINT PLAN TO BATTLE COVID-19
Pfizer has called on the biopharmaceutical industry to join it in committing to unprecedented collaboration to combat COVID-19, issuing a five-point plan, which includes applying its drug development expertise, especially to help smaller companies, and offering its manufacturing capabilities.
COVID-19 NEWS
Nemera
Nemera highlights obligation to provide life-saving devices to most vulnerable – including the elderly, asthmatics, diabetics
PRESS RELEASE In its COVID-19 press update, Nemera has highlighted its obligation to provide life-saving […]
COVID-19 NEWS
Sensirion
The world in a state of emergency: How Sensirion helps save lives worldwide
Sensirion is lending its support to manufacturers of respiratory devices around the world to ensure their equipment is fitted with exceptionally accurate sensor technology allowing for time-resolved flow and volume measurements.
COVID-19 NEWS
Stevanato Group
Stevanato guarantees primary packaging supplies for pharma glass containers and integrated medical device solutions
In its COVID-19 announcement, Stevanato Group has confirmed that as a major manufacturer of glass containers for pharma and a supplier of integrated solutions for medical devices is guaranteeing primary packaging supplies to support patient care worldwide.
COVID-19 NEWS
Aptar Pharma
Aptar Group Releases COVID-19 Update for its Customers and Partners
Aptar Pharma has released a message from its President and Chief Executive Officer to provide a COVID-19 update to inform its customers and partners of the measures the Group is taking in regards to the evolving coronavirus pandemic in order to continue to support our customers.
COVID-19 NEWS
AS DEMAND SURGES, NEPHRON PREPARED TO MEET AMERICA’S NEEDS FOR RESPIRATORY MEDS
Nephron Pharmaceuticals has released a statement detailing how current demand for its medications - inhalation solutions and suspension products that treat respiratory conditions - is surging and the company is shattering sales records.
COVID-19 NEWS
Synairgen to start trial of SNG001 in COVID-19 imminently
Synairgen has announced that it has received expedited approvals from the UK Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) to conduct a trial of SNG001 (inhaled formulation of interferon-beta-1a) in COVID-19 patients to assist with the global outbreak of the virus.
COVID-19 NEWS
US FDA Issues Guidance for Conducting Clinical Trials during the COVID-19 pandemic.
“With this guidance issued today, the FDA is helping industry and investigators navigate the COVID-19 […]
COVID-19 NEWS
MannKind
MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic
MannKind Corporation is adjusting R&D resources that were reserved for its pipeline of investigational products for treating serious lung diseases, with the goal of prioritising work on new compounds that may have the potential to address the morbidity and mortality associated with respiratory viral infections, such as COVID-19.
COVID-19 NEWS
PBOA Members Committed To Continuing To Reliably Manufacture Drug and Vaccine Products
PBOA reports how its member companies remain committed to serving patients by manufacturing effective, quality products for their customers, during this global health crisis, and report no material disruptions to their operations.
COVID-19 NEWS
Insmed Provides Covid-19 Business Update
Insmed implements corporate initiatives in response to the novel coronavirus (SARS-CoV-2) global pandemic including a remote working policy to allow infectious disease specialists and pulmonologists to focus on treating patients and containing the virus. Arikares trainers will now offer remote training and onboarding for patients who initiate treatment with ARIKAYCE.
COVID-19 NEWS
Beyond Air
Beyond Air Submits Investigational Device Exemption to FDA for the Treatment of COVID-19
Beyond Air has submitted an IDE to the US FDA for use of its LungFit™ BRO system in the treatment of COVID-19 patients stating that a mounting body of evidence that NO is safe and well tolerated and
in vitro
evidence points to inhibition of viral replication in coronaviruses.
1
2
Next
Top
This website uses functional cookies (but not advertising cookies). View our
Privacy Policy
.
Close
Privacy & Cookies Policy
W3 Total Cache is currently running in Pro version Development mode.